Definium Executives Execute Massive Zero‑Cost Buy‑Spree, Signaling Bold Confidence Ahead of Clinical Milestones
Insider buying at Definium shows management confidence amid volatile market – a bullish cue for long‑term investors seeking upside.
3 minutes to read